Origin Therapeutics Holdings Inc.
Origin Therapeutics Holdings is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The Company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector.
Origin Therapeutics Holdings Inc. (ORIG)
le juin 2/June 2022
The common shares of Origin Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.